Rate My Professor Yeng Yeo

Dr. Wendy Wai Yeng Yeo is a Lecturer in the Malaysia School of Pharmacy at Monash University, Faculty of Pharmacy and Pharmaceutical Sciences. She earned her Bachelor of Science with Honours in Biochemistry and Master of Science in Medical Biotechnology from Universiti Putra Malaysia, followed by a PhD in Medical Biotechnology with a co-tutelle joint degree in Health Biology from Universiti Putra Malaysia and Université de Montpellier, France. Before joining Monash University Malaysia, she instructed graduate entry medicine students at Perdana University Graduate School of Medicine and pharmacy students at Lincoln University College. Earlier in her career, she served as a production scientist at Tessa Therapeutics, a biotechnology firm focused on research, clinical development, and commercialization of cancer immunotherapy treatments. She has been an affiliate member of the Young Scientists Network-Academy of Sciences Malaysia since 2015.

Dr. Yeo's research interests center on regenerative medicine, medical biotechnology, gene therapy, stem cells, and translational medicine. She has produced 19 research outputs, including peer-reviewed articles, book chapters, and conference papers. Key publications include 'Opportunities and challenges of 5G network technology toward precision medicine' (2023, Clinical and Translational Science, co-authored with C.C. Kang et al.), 'Photoactivated riboflavin inhibits planktonic and biofilm growth of Candida albicans and non-albicans Candida species' (2024), 'Medical equipment engineering in ESG and green sustainable technology' (2024, book chapter), and earlier influential works such as 'Advancements in reprogramming strategies for the generation of induced pluripotent stem cells' (2011, Journal of Assisted Reproduction and Genetics, cited 60 times) and 'Gene transfer into the lung by nanoparticle dextran-spermine/plasmid DNA complexes' (2010, BioMed Research International, cited 58 times). Her contributions extend to topics like miRNA therapies in spinal muscular atrophy and plant secondary metabolites for antimicrobial resistance. In 2025, she received the PVC's Commendation for Excellence in Equity, Diversity and Inclusion. Her scholarship impacts fields including precision medicine, stem cell applications, and innovative healthcare technologies.